4//SEC Filing
Regnante Keith 4
Accession 0001415889-24-004003
CIK 0001664710other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:40 PM ET
Size
5.5 KB
Accession
0001415889-24-004003
Insider Transaction Report
Form 4
Regnante Keith
CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-13+40,000→ 40,000 totalExercise: $56.18Exp: 2034-02-12→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on February 13, 2025, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001682068
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 8:40 PM ET
- Size
- 5.5 KB